Corbus Pharmaceuticals Holdings (CRBP) Other Non Operating Income (2013 - 2025)

Corbus Pharmaceuticals Holdings' Other Non Operating Income history runs 13 years deep, the most recent figure standing at -$50000.0 for Q3 2025.

• In Q3 2025, Other Non Operating Income fell 125.0% year-over-year to -$50000.0; the TTM figure through Sep 2025 stood at $2.5 million (down 47.63% YoY), while the FY2024 annual figure was $4.1 million, up 51.08% from the prior year.
• Other Non Operating Income for Q3 2025 stood at -$50000.0, down from $176000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $12.0 million in Q3 2021, with the low at -$267823.0 in Q1 2022.
• The 5-year median for Other Non Operating Income is $183000.0 (2023), against an average of $1.0 million.
• The sharpest annual moves came in 2021 and 2022: Other Non Operating Income jumped 4891.8% in 2021, then tumbled 1706.42% in 2022.
• Corbus Pharmaceuticals Holdings' Other Non Operating Income stood at $109664.0 in 2021, then soared by 69.91% to $186330.0 in 2022, then jumped by 1008.79% to $2.1 million in 2023, then tumbled by 37.32% to $1.3 million in 2024, then sank by 103.86% to -$50000.0 in 2025.
• Business Quant data shows CRBP's Other Non Operating Income at -$50000.0 in Q3 2025, $176000.0 in Q2 2025, and $1.1 million in Q1 2025.